Genetic Polymorphisms of Peroxisome Proliferator-Activated Receptors and the Risk of Cardiovascular Morbidity and Mortality in a Community-Based Cohort in Washington County, Maryland
Saved in:
Main Authors: | Kathy J. Helzlsouer, Sandra C. Hoffman, Paul Strickland, Han-Yao Huang, Bindu Kalesan, L. Gallicchio |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/276581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
by: Jean Dallongeville, et al.
Published: (2009-01-01) -
Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
by: Ahmad Aljada, et al.
Published: (2009-01-01) -
The Maryland colony
by: Mason, F. van Wyck (Francis van Wyck), 1901-1978
Published: (1969) -
Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
by: Jihan Youssef, et al.
Published: (2002-01-01) -
Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology
by: Yin-Feng Zhang, et al.
Published: (2018-01-01)